Barry Porter

785 citations

31 papers · 535 indexed · h-index 13

Impact in

Organic Chemistry top 10%
- Asymmetric Synthesis and Catalysis
- Synthetic Organic Chemistry Methods
- Cyclopropane Reaction Mechanisms
- Catalytic C–H Functionalization Methods
- Oxidative Organic Chemistry Reactions
Toxicology top 10%

Papers in ⓘ

Molecular Biology 15
- Receptor Mechanisms and Signaling 6
- Chemical Synthesis and Analysis 4
Organic Chemistry 14
- Asymmetric Synthesis and Catalysis 8
- Free Radicals and Antioxidants 3
- Organic Chemistry Cycloaddition Reactions 2

Co-authors: Barry C. Ross (4 shared papers)Ernest Wenkert (10 shared papers)Christopher J. Moody (1 shared paper)Martyn J. Deal (2 shared papers)Andrew B. McElroy (2 shared papers)Rodolfo Lavilla (1 shared paper)Jyh‐Horng Sheu (1 shared paper)Christopher Jordan (2 shared papers)
Journals: The Journal of Organic Chemistry (11 papers)Journal of Medicinal Chemistry (9 papers)Phytochemistry (3 papers)European Journal of Medicinal Chemistry (2 papers)Synlett (2 papers)
Partner nations: United Kingdom Brazil United States

In The Last Decade

Barry Porter

31 papers receiving 494 citations

Peers

Countries citing papers authored by Barry Porter

Since Specialization

Citations

This map shows the geographic impact of Barry Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Porter more than expected).

Fields of papers citing papers by Barry Porter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Porter. The network helps show where Barry Porter may publish in the future.

Co-authors

The 25 scholars most cited alongside Barry Porter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barry Porter Line = papers co-authored together Barry Porter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Highly potent and selective heptapeptide antagonists of the neurokinin NK-2 receptor Journal of Medicinal Chemistry ·Andrew B. McElroy, Stephen P. Clegg, Martyn J. Deal, George B. Ewan, Russell M. Hagan, S.J. Ireland, Christopher Jordan, Barry Porter, Barry C. Ross	1992	62
2	Polyene synthesis. Ready construction of retinol-carotene fragments, (.+-.)-6(E)-LTB3 leukotrienes, and corticrocin The Journal of Organic Chemistry ·Ernest Wenkert, Ming Guo, Rodolfo Lavilla, Barry Porter, Kishore Ramachandran, Jyh‐Horng Sheu	1990	60
3	Synthesis of the staurosporine aglycon The Journal of Organic Chemistry ·Christopher J. Moody, Kulsum F. Rahimtoola, Barry Porter, Barry C. Ross	1992	52
4	Orally Active Non-Peptide Fibrinogen Receptor (GpIIb/IIIa) Antagonists: Identification of 4-[4-[4-(Aminoimino methyl)phenyl]-1-piperazinyl]-1- piperidineacetic Acid as a Long-Acting, Broad-Spectrum Antithrombotic Agent Journal of Medicinal Chemistry ·Colin Eldred, Brian Evans, Sean J. Hindley, Brian D. Judkins, Henry Ansgar Kelly, John R. Kitchin, Philip Lumley, Barry Porter, Barry C. Ross	1994	37
5	Selective ET_AAntagonists. 5. Discovery and Structure−Activity Relationships of Phenoxyphenylacetic Acid Derivatives Journal of Medicinal Chemistry ·Peter C. Astles, Thomas J. Brown, Frank Halley, Caroline M. Handscombe, Neil V. Harris, Tahir Majid, Clive McCarthy, Iain M. McLay, Andrew Morley, Barry Porter, Alan G. Roach, Carol A. Sargent, Christopher Smith, R. J. A. WALSH	2000	32
6	Conformationally constrained tachykinin analogs: potent and highly selective neurokinin NK-2 receptor agonists Journal of Medicinal Chemistry ·Martyn J. Deal, Russell M. Hagan, S.J. Ireland, Christopher Jordan, Andrew B. McElroy, Barry Porter, Barry C. Ross, M. Stephens-Smith, P. Ward	1992	26
7	Thermal transformation of alkenoylated aziridines into ring-fused pyrrolidines The Journal of Organic Chemistry ·David Wenkert, Stephen B. Ferguson, Barry Porter, Anders Qvarnstrom, Andrew T. McPhail	1985	20
8	Bile acids with a cyclopropyl-containing side chain. 3. Separation, identification, and properties of all four stereoisomers of 3.alpha.,7.beta.-dihydroxy-22,23-methylene-5.beta.-cholan-24-oic acid Journal of Medicinal Chemistry ·Roberto Pellicciari, Benedetto Natalini, Sergio Cecchetti, Barry Porter, Aldo Roda, Brunella Grigolo, Renzo Balducci	1988	18
9	The structure of sagittariol Phytochemistry ·Shekhar C. Sharma, J.S. Tandon, Barry Porter, M. S. RAJU, Ernest Wenkert	1984	17
10	New non peptidic C5a receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Peter C. Astles, Thomas J. Brown, Paul Alan Cox, Frank Halley, Peter Lockey, Clive McCarthy, Iain M. McLay, Tahir Majid, Andrew Morley, Barry Porter, Andrew J. Ratcliffe, R. J. A. WALSH	1997	17
11	Diels-Alder reactions of cycloalkenones. 9. Diastereofacial selectivity of mono- and dialkylated 2-cyclohexenones The Journal of Organic Chemistry ·E. Charles Angell, Francesco Fringuelli, Ferdinando Pizzo, Barry Porter, Aldo Taticchi, Ernest Wenkert	1986	17
12	Selective Endothelin A Receptor Antagonists. 3. Discovery and Structure−Activity Relationships of a Series of 4-Phenoxybutanoic Acid Derivatives Journal of Medicinal Chemistry ·Peter C. Astles, Clive Brealey, Thomas J. Brown, Vincenzo Facchini, Caroline M. Handscombe, Neil V. Harris, Clive McCarthy, Iain M. McLay, Barry Porter, Alan G. Roach, Carol A. Sargent, Christopher Smith, R. J. A. WALSH	1998	16
13	Acyl-CoA:CholesterolO-Acyltransferase (ACAT) Inhibitors. 2. 2-(1,3-Dioxan-2-yl)-4,5-diphenyl-1H-imidazoles as Potent Inhibitors of ACAT Journal of Medicinal Chemistry ·Peter C. Astles, Michael J. Ashton, Andrew W. Bridge, Neil V. Harris, Terrance W. Hart, David P. Parrott, Barry Porter, David Riddell, Christopher Smith, Robert J. Williams	1996	14
14	Abutasterone, an ecdysone from abuta velutina Phytochemistry ·Maria Lúcia B. Pinheiro, Wilson Wolter Filho, Arnaldo I. Da Rocha, Barry Porter, Ernest Wenkertt	1983	12
15	Selective Endothelin A Receptor Antagonists. 4. Discovery and Structure−Activity Relationships of Stilbene Acid and Alcohol Derivatives Journal of Medicinal Chemistry ·Peter C. Astles, Thomas J. Brown, Frank Halley, Caroline M. Handscombe, Neil V. Harris, Clive McCarthy, Iain M. McLay, Peter Lockey, Tahir Majid, Barry Porter, Alan G. Roach, Christopher Smith, R. J. A. WALSH	1998	12
16	Synthesis of 20-epipseudoaspidospermidine, 20-epidehydropseudoaspidospermidine, and 20-epipseudovincadifformine The Journal of Organic Chemistry ·Ernest Wenkert, Barry Porter, Dana P. Simmons, Janick Ardisson, Nicole Kunesch, Jacques Poisson	1984	11
17	Diels-Alder reactions of cycloalkenones. 4. Short syntheses of some cadinenes The Journal of Organic Chemistry ·Francesco Fringuelli, Ferdinando Pizzo, Aldo Taticchi, Vı́tor F. Ferreira, Enrique L. Michelotti, Barry Porter, Ernest Wenkert	1985	11
18	Synthesis of α-amino acids using amino acid γ-anion equivalents: synthesis of 5-oxo α-amino acids, homophenylalanine derivatives and pentenylglycines Journal of the Chemical Society Perkin Transactions 1 ·Richard F. W. Jackson, Joanne L. Fraser, Neil Wishart, Barry Porter, Martin Wythes	1998	11
19	Diels-Alder reactions of cycloalkenones. 10. Endo-exo diastereoselectivity of 2-cyclohexenones The Journal of Organic Chemistry ·E. Charles Angell, Francesco Fringuelli, Lucio Minuti, Ferdinando Pizzo, Barry Porter, Aldo Taticchi, Ernest Wenkert	1986	11
20	Studies on the Molecular Mechanism of the Radioprotective Effect of Serotonin Radiation Research ·W. Lohmann, A. J. Moss, James Lynn Sanders, Barry Porter, D. M. Woodall	1966	10

About Barry Porter

Barry Porter is a scholar working on Molecular Biology, Organic Chemistry, Physiology, Spectroscopy and Biophysics, having authored 31 papers that have together received 535 indexed citations. Recurring topics across this work include Asymmetric Synthesis and Catalysis (8 papers), Receptor Mechanisms and Signaling (6 papers), Molecular spectroscopy and chirality (5 papers), Nitric Oxide and Endothelin Effects (5 papers), Chemical Synthesis and Analysis (4 papers), Electron Spin Resonance Studies (4 papers), Free Radicals and Antioxidants (3 papers) and Organic Chemistry Cycloaddition Reactions (2 papers). The work is most often cited by research in Organic Chemistry (297 citations), Toxicology (23 citations), Cellular and Molecular Neuroscience (81 citations), Pharmacology (31 citations) and Pharmaceutical Science (21 citations). Barry Porter has collaborated with scholars based in United Kingdom, Brazil and United States. Frequent co-authors include Barry C. Ross, Ernest Wenkert, Christopher J. Moody, Martyn J. Deal, Andrew B. McElroy, Rodolfo Lavilla, Jyh‐Horng Sheu, Christopher Jordan, Russell M. Hagan and Ming Guo. Their work appears in journals such as The Journal of Organic Chemistry, Journal of Medicinal Chemistry, Phytochemistry, European Journal of Medicinal Chemistry and Synlett.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact